These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 16959304)
1. Nadroparine activated fibrinolysis and improvement of glomerular filtration rate in patients with FIGO IIB-IIIB cervical cancer treated with radiochemotherapy. Derlatka P; Bidzinski M; Stachurska E; Benke M Gynecol Oncol; 2007 Jan; 104(1):24-31. PubMed ID: 16959304 [TBL] [Abstract][Full Text] [Related]
2. Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB "bulky". Sreenivasa G; Hildebrandt B; Kümmel S; Jungnickel K; Cho CH; Tilly W; Böhmer D; Budach V; Felix R; Wust P Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1159-67. PubMed ID: 16979843 [TBL] [Abstract][Full Text] [Related]
3. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment. Miralbell R; Sancho G; Bieri S; Carrió I; Helg C; Brunet S; Martin PY; Sureda A; Gomez De Segura G; Chapuis B; Estorch M; Ozsahin M; Keller A Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):809-16. PubMed ID: 14967438 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA. Kornovski Y; Gorchev G J BUON; 2006; 11(3):291-7. PubMed ID: 17309152 [TBL] [Abstract][Full Text] [Related]
5. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z; Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787 [TBL] [Abstract][Full Text] [Related]
6. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904 [TBL] [Abstract][Full Text] [Related]
7. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer. Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518 [TBL] [Abstract][Full Text] [Related]
8. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy]. Torbé B Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807 [TBL] [Abstract][Full Text] [Related]
9. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications. Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836 [TBL] [Abstract][Full Text] [Related]
10. [Cystatin C as a marker of glomerular filtration rate in patients with ovarian cancer]. Bodnar L; Wcisło GB; elichowski G; Raczka A; Wańkowicz Z; Szczylik C Pol Merkur Lekarski; 2008 Apr; 24(142):307-11. PubMed ID: 18634361 [TBL] [Abstract][Full Text] [Related]
11. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. Dittrich HC; Gupta DK; Hack TC; Dowling T; Callahan J; Thomson S J Card Fail; 2007 Oct; 13(8):609-17. PubMed ID: 17923351 [TBL] [Abstract][Full Text] [Related]
12. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932 [TBL] [Abstract][Full Text] [Related]
13. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer. Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825 [TBL] [Abstract][Full Text] [Related]
14. Renal outcome after ciclosporin-induced nephrotoxicity. Tostivint I; du Montcel ST; Jaudon MC; Mallet A; Le Hoang P; Bodaghi B; Deray G; Bagnis CI Nephrol Dial Transplant; 2007 Mar; 22(3):880-5. PubMed ID: 17127700 [TBL] [Abstract][Full Text] [Related]
15. Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients. Bragadottir G; Redfors B; Nygren A; Sellgren J; Ricksten SE Acta Anaesthesiol Scand; 2009 Sep; 53(8):1052-9. PubMed ID: 19572935 [TBL] [Abstract][Full Text] [Related]
16. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400 [TBL] [Abstract][Full Text] [Related]
17. Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. Kim YT; Kim SW; Yoon BS; Cho HJ; Nahm EJ; Kim SH; Kim JH; Kim JW Gynecol Oncol; 2007 Apr; 105(1):199-204. PubMed ID: 17234260 [TBL] [Abstract][Full Text] [Related]
18. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin. Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859 [TBL] [Abstract][Full Text] [Related]
19. Clinical results of medium dose rate brachytherapy combined with external beam radiotherapy in the treatment of advanced cervical carcinoma. Ordeanu C; Coza O; Gavris S; Todor N; Szilagy E; Bako M; Cernea V; Ghilezan N; Nagy V J BUON; 2007; 12(2):221-6. PubMed ID: 17600876 [TBL] [Abstract][Full Text] [Related]
20. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Franckena M; Stalpers LJ; Koper PC; Wiggenraad RG; Hoogenraad WJ; van Dijk JD; Wárlám-Rodenhuis CC; Jobsen JJ; van Rhoon GC; van der Zee J Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1176-82. PubMed ID: 17881144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]